A plant-based expression system could provide greater speed and capacity at a comparatively low cost.
Frédéric Ors
Advertisement
Frédéric Ors is vice-president of business development at Medicago
Articles by Frédéric Ors
Advertisement
Latest Updated Articles
Plants As an Innovative and Accelerated Vaccine-Manufacturing SolutionPublished: May 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
